Capstone Investment Advisors’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $974K | Sell |
4,100
-2,200
| -35% | -$457K | ﹤0.01% | 955 |
|
|
2026
Q1 | $1.33M | Buy |
6,300
+1,500
| +31% | +$323K | ﹤0.01% | 758 |
|
|
2025
Q4 | $986K | Sell |
4,800
-2,000
| -29% | -$376K | ﹤0.01% | 869 |
|
|
2025
Q3 | $1.07M | Sell |
6,800
-2,900
| -30% | -$448K | ﹤0.01% | 989 |
|
|
2025
Q2 | $1.63M | Sell |
9,700
-17,400
| -64% | -$2.58M | ﹤0.01% | 711 |
|
|
2025
Q1 | $3.73M | Sell |
27,100
-10,900
| -29% | -$1.39M | 0.01% | 528 |
|
|
2024
Q4 | $4.49M | Buy |
38,000
+15,500
| +69% | +$1.81M | 0.01% | 590 |
|
|
2024
Q3 | $2.49M | Buy |
22,500
+2,900
| +15% | +$303K | 0.01% | 664 |
|
|
2024
Q2 | $1.93M | Buy |
19,600
+4,000
| +26% | +$408K | 0.01% | 733 |
|
|
2024
Q1 | $1.75M | Sell |
15,600
-11,900
| -43% | -$1.28M | 0.01% | 843 |
|
|
2023
Q4 | $2.77M | Buy |
27,500
+13,600
| +98% | +$1.35M | 0.01% | 719 |
|
|
2023
Q3 | $1.21M | Buy |
13,900
+4,600
| +49% | +$416K | 0.01% | 917 |
|
|
2023
Q2 | $880K | Hold |
9,300
| – | – | ﹤0.01% | 916 |
|
|
2023
Q1 | $702K | Sell |
9,300
-11,400
| -55% | -$860K | ﹤0.01% | 900 |
|
|
2022
Q4 | $1.59M | Hold |
20,700
| – | – | 0.01% | 779 |
|
|
2022
Q3 | $1.38M | Buy |
20,700
+2,700
| +15% | +$171K | 0.01% | 906 |
|
|
2022
Q2 | $941K | Sell |
18,000
-56,500
| -76% | -$3.21M | ﹤0.01% | 1047 |
|
|
2022
Q1 | $4.22M | Sell |
74,500
-132,200
| -64% | -$7.08M | 0.01% | 764 |
|
|
2021
Q4 | $10.6M | Buy |
206,700
+5,200
| +3% | +$255K | 0.02% | 582 |
|
|
2021
Q3 | $9.97M | Buy |
201,500
+13,800
| +7% | +$749K | 0.02% | 623 |
|
|
2021
Q2 | $10.7M | Buy |
187,700
+76,000
| +68% | +$4.44M | 0.02% | 518 |
|
|
2021
Q1 | $6.79M | Buy |
111,700
+41,900
| +60% | +$2.31M | 0.02% | 566 |
|
|
2020
Q4 | $3.74M | Sell |
69,800
-5,100
| -7% | -$265K | 0.01% | 685 |
|
|
2020
Q3 | $3.52M | Buy |
74,900
+16,300
| +28% | +$836K | 0.02% | 611 |
|
|
2020
Q2 | $3.06M | Buy |
58,600
+19,300
| +49% | +$995K | 0.02% | 575 |
|
|
2020
Q1 | $1.88M | Sell |
39,300
-81,300
| -67% | -$4.22M | 0.03% | 543 |
|
|
2019
Q4 | $6.1M | Buy |
120,600
+56,200
| +87% | +$2.9M | 0.03% | 486 |
|
|
2019
Q3 | $3.04M | Sell |
64,400
-500
| -0.8% | -$22.8K | 0.02% | 608 |
|
|
2019
Q2 | $3.06M | Buy |
64,900
+24,300
| +60% | +$1.12M | 0.02% | 616 |
|
|
2019
Q1 | $1.96M | Buy |
40,600
+19,900
| +96% | +$997K | 0.02% | 611 |
|
|
2018
Q4 | $923K | Buy |
20,700
+6,100
| +42% | +$318K | 0.01% | 642 |
|
|
2018
Q3 | $788K | Buy |
+14,600
| New | +$747K | 0.01% | 670 |
|
Other funds holding CAH
Capstone Investment Advisors's CAH Position: Q2 2026 in Review
Capstone Investment Advisors reduced its Cardinal Health (CAH) stake by 25% in Q2 2026, selling an estimated $150K and leaving 2,203 shares worth $523K. The position accounts for ﹤0.01% of the portfolio, ranked #1223.
Capstone Investment Advisors first reported a position in CAH in Q3 2015 and has held it in 20 quarters since. The position peaked at $3.5M in Q3 2021. 1,501 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Capstone Investment Advisors held 2,203 shares of Cardinal Health worth $523K as of Q2 2026.
- Capstone Investment Advisors sold 720 Cardinal Health shares in Q2 2026, an estimated $150K.
- Cardinal Health made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1223 holding.
- Capstone Investment Advisors first reported a position in Cardinal Health in Q3 2015 and has held it in 20 quarters since.
- Capstone Investment Advisors's Cardinal Health position peaked at $3.5M in Q3 2021.
- 1,501 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.